IFRX InflaRx N.V.
10,438
$1.24
$0.055
(4.25%)
| Watchers | 10,438 |
| 52-Wk Low | $1.14 |
| 52-Wk High | $5.20 |
| Market Cap | $73.02M |
| Volume | 187,160.00 |
| 52-Wk High | $5.20 |
| 52-Wk Low | $1.14 |
InflaRx N.V. Announces 2024 AGM DetailsTipRanks Financial Blog • about 1 month ago
Inflarx N.V. (IFRX) has released an update. InflaRx N.V. has announced its annual general meeting (AGM) to be held in Amsterdam on April 25, 2024...
Share to Feed
InflaRx (NASDAQ:IFRX Get Free Report)s stock had its buy rating restated by HC Wainwright in a research note issued to investors on Friday, Benzinga reports. They...
Related Stocks: NAS:IFRX...
InflaRx reports FY results...
InflaRx will focus development activities and resources initially on selected indications in immuno-dermatology, with registrational-phase vilobelimab and potentially best-in-class oral C5aR...
JENA, Germany, March 19, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...
Agios Pharmaceuticals (NASDAQ:AGIO Get Free Report) and InflaRx (NASDAQ:IFRX Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the...
JENA, Germany, Feb. 22, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...
InflaRx (NASDAQ:IFRX Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 307,000 shares, a...